Lucas Santana dos Santos

Lucas Santana dos Santos serves as an Assistant Professor in the Department of Pathology at the Feinberg School of Medicine, Northwestern University, specializing in Genomic Pathology. His work bridges advanced molecular diagnostics with clinical oncology applications across multiple cancer types.

His educational background includes:

• PhD from the University of Pittsburgh (2017)

Dr. Santana dos Santos' research centers on molecular pathology and genomic diagnostics, with emphasis on cancer genomics, liquid biopsy development, and clinical validation of genomic biomarkers. His expertise spans hematopathology (particularly acute myeloid leukemia) and solid tumor genomics (notably pancreatic cancer), focusing on translating genomic discoveries into diagnostic tools for precision oncology.

Recent publications (2024-2025) demonstrate consistent translational focus across four key domains: molecular classification of metastatic cancers, circulating tumor DNA biomarkers in pancreatic cancer, cytogenetic risk stratification in leukemia, and clinical validation of epigenetic testing methods. These works collectively advance genomic pathology's role in resolving diagnostic uncertainties and improving cancer management.

Professional disclosures indicate industry engagement including ownership interest in Tempus Labs and collaborations with pharmaceutical/biotechnology firms, reflecting his work's translational impact.

Details regarding graduate student mentorship and active research grants are not specified in available materials.

He operates within Northwestern's Genomic Pathology division but specific laboratory infrastructure details are not publicly documented.